Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
An overview of situations where market-cap weighted benchmarks are appropriate and practical tips for effective performance comparison.
28,411 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Anchorage Digital confirms it holds Strategy’s STRC perpetual preferred stock, marking a high-profile move by a regul...
As Wall Street eyes the next stock split, ASML, Lilly, and TransDigm sit near the top of the list. Analysts say the o...
Marvell Technology has bold dreams about joining the trillion-dollar club. This article lays out a practical timeline...
Could investing $10,000 walmart really boost your wealth? This guide dives into Walmart's growth story, realistic ret...
A new venue now enables 24/7 crypto trading, including weekends. Early weekend data shows growing interest and liquid...
A long-dormant market indicator has flashed, raising questions about the pace of the rally as the midterm election cy...
Geopolitics remains a market driver, but traders say wall street more focused on Iranian official remarks rather than...
ServiceNow has built a durable software platform with strong margins and steady growth. This article explains why the...
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
Markets shift, and healthcare REITs face unique pressures. This guide helps you decide if it’s time dump your shares ...
A director sold 33,000 Clear Secure shares worth about $1.5 million, sparking questions about the stock's outlook. Th...